Last edition
News about
H.E.L Group Introduces Two New Bioreactors to Support Bioprocess Development
H.E.L Group has announced the expansion of its BioXplorer range with two new automated parallel bioreactors.
GEODIS Strengthens Pharma Capabilities in the Americas With Seven IATA CEIV Pharma Certifications
GEODIS, a world leader in transport and logistics, announced today it has strengthened its air freight temperature-controlled pharma shipment capabilities across the Americas region by earning IATA's Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification across seven sites in the United States.
Purolite Expands Bioprocessing Production Capacity with New U.S. Facility
Ecolab Inc., a company involved in water, hygiene, and infection prevention, is expanding its Purolite business with the addition of a new biologics resin manufacturing facility in Landenberg, PA.
Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes
Integration of Sartorius' process scale multi-column chromatography with Waters' process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics.
Steriline and INCOME, two renowned names synonymous with quality and service in the Indian pharmaceutical industry for the past three decades, announce the establishment of Steriline Asia Pvt. Ltd. This strategic move aims to enhance their footprint on the Indian subcontinent and cater to the evolving needs of the industry.
Aurobindo Pharma completes plant installation in China
Aurobindo Pharma has completed the installation of its plant in China and is planning to commission it in the first quarter of next fiscal, said Santhanam Subramanian, Chief Financial Officer of the company.
China's Fosun to build African drug manufacturing plant with help from World Bank
China’s Fosun Pharma plans to build a facility in the Ivory Coast to manufacture anti-malaria drugs and antibacterial medicines with the help of a 100 million euro ($106 million) loan from the International Finance Corporation (IFC).
Intas gets USFDA Import Alert but allowed to supply 24 critical drugs
Intas Pharmaceuticals Limited has informed that its manufacturing facility SEZ (Pharmez) near Ahmedabad has been listed under ‘Import Alert’ by the US Food and Drug Administration (USFDA).
Indoco Remedies Ltd's Sterlie Facility at Goa receives Form 483 with 4 observations from USFDA
The United States Food and Drug Administration (USFDA) had inspected Indoco Remedies Limited's Sterile Facility (Plant II) located at Goa("Facility"), from February 20, 2023 to February 28, 2023.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy